1. Contractors
  2. Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc

Federal contractor · Research and Development in Biotechnology

Regeneron Pharmaceuticals has 3 federal contracts of $100,000 or more active since October 2023, with $1.26B obligated, from 1 agency. 2 are still running, 1 ending within 18 months.

Contracts
3 since FY2024$1,261,006,207 obligated, contracts of $100,000 or more
Running now
2 contracts
Biggest customer
Office of Assistant Secretary for Preparedness and Response$1.26B on 3 contracts
UEI
N3F9MH7E6HD6Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
- Regeneron Other Transaction Authority (Ota) AwardOffice of Assistant Secretary for Preparedness and Response · HHSO100201700020C$278,844,172Sep 25, 2027in 10 monthsNY
IGF::OT::IGFOffice of Assistant Secretary for Preparedness and Response · HHSO100201700016C$973,560,407Sep 29, 2031in 58 monthsNY

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount, $M
Office of Assistant Secretary for Preparedness and Response3 contracts1,261

What they sell

IndustryAmount, $M
Research and Development in BiotechnologyNAICS 541711 · 3 contracts1,261

Where the work is

Place of workAmount, $M
New York3 contracts1,261

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Regeneron Pharmaceuticals's work

New contract opportunities under NAICS 541711, research and development in biotechnology, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy